Pro Medicus Limited (ASX:PME)
Australia
· Delayed Price · Currency is AUD 132.70
+11.21 (9.23%)
At close: Mar 6, 2026
Pro Medicus Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 240.57 | 212.98 | 161.5 | 124.9 | 93.46 | 67.88 | Upgrade
|
| Other Revenue | - | - | - | - | - | 0.18 | Upgrade
|
| Revenue | 240.57 | 212.98 | 161.5 | 124.9 | 93.46 | 68.06 | Upgrade
|
| Revenue Growth (YoY) | 30.33% | 31.87% | 29.30% | 33.64% | 37.31% | 19.79% | Upgrade
|
| Cost of Revenue | 0.32 | 0.31 | 0.3 | 0.54 | 0.47 | 0.49 | Upgrade
|
| Gross Profit | 240.25 | 212.67 | 161.2 | 124.36 | 93 | 67.57 | Upgrade
|
| Selling, General & Admin | 55.47 | 47.04 | 38.7 | 31.07 | 21.56 | 16.76 | Upgrade
|
| Other Operating Expenses | -1.48 | 0.61 | 1.21 | 1.29 | 2.8 | 0.99 | Upgrade
|
| Operating Expenses | 61.72 | 54.88 | 48.41 | 40.28 | 31.68 | 24.94 | Upgrade
|
| Operating Income | 178.53 | 157.79 | 112.79 | 84.08 | 61.31 | 42.63 | Upgrade
|
| Interest & Investment Income | 8.12 | 7.56 | 4.83 | 2.43 | 0.65 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -2.18 | -2.03 | -1.12 | -0.39 | 1.12 | 0.24 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0 | - | - | Upgrade
|
| Pretax Income | 333.34 | 163.31 | 116.5 | 86.13 | 63.08 | 42.87 | Upgrade
|
| Income Tax Expense | 98.65 | 48.1 | 33.7 | 25.48 | 18.64 | 12.02 | Upgrade
|
| Net Income | 234.7 | 115.22 | 82.79 | 60.65 | 44.44 | 30.85 | Upgrade
|
| Net Income to Common | 234.7 | 115.22 | 82.79 | 60.65 | 44.44 | 30.85 | Upgrade
|
| Net Income Growth | 138.78% | 39.16% | 36.52% | 36.47% | 44.06% | 33.69% | Upgrade
|
| Shares Outstanding (Basic) | 104 | 104 | 104 | 104 | 104 | 104 | Upgrade
|
| Shares Outstanding (Diluted) | 105 | 105 | 105 | 105 | 105 | 105 | Upgrade
|
| Shares Change (YoY) | 0.04% | 0.01% | 0.06% | 0.01% | -0.01% | 0.13% | Upgrade
|
| EPS (Basic) | 2.25 | 1.10 | 0.79 | 0.58 | 0.43 | 0.30 | Upgrade
|
| EPS (Diluted) | 2.24 | 1.10 | 0.79 | 0.58 | 0.42 | 0.29 | Upgrade
|
| EPS Growth | 138.73% | 39.19% | 36.38% | 36.47% | 44.07% | 33.48% | Upgrade
|
| Free Cash Flow | 127.37 | 110.89 | 81.67 | 62.24 | 61.34 | 38.71 | Upgrade
|
| Free Cash Flow Per Share | 1.22 | 1.06 | 0.78 | 0.59 | 0.59 | 0.37 | Upgrade
|
| Dividend Per Share | 0.620 | 0.550 | 0.400 | 0.300 | 0.220 | 0.150 | Upgrade
|
| Dividend Growth | 31.91% | 37.50% | 33.33% | 36.36% | 46.67% | 25.00% | Upgrade
|
| Gross Margin | 99.87% | 99.86% | 99.81% | 99.56% | 99.50% | 99.28% | Upgrade
|
| Operating Margin | 74.21% | 74.09% | 69.84% | 67.32% | 65.60% | 62.63% | Upgrade
|
| Profit Margin | 97.56% | 54.10% | 51.27% | 48.56% | 47.55% | 45.32% | Upgrade
|
| Free Cash Flow Margin | 52.95% | 52.07% | 50.57% | 49.83% | 65.63% | 56.88% | Upgrade
|
| EBITDA | 178.91 | 158.12 | 113.06 | 84.37 | 61.59 | 42.89 | Upgrade
|
| EBITDA Margin | 74.37% | 74.24% | 70.00% | 67.55% | 65.89% | 63.02% | Upgrade
|
| D&A For EBITDA | 0.38 | 0.33 | 0.27 | 0.29 | 0.27 | 0.26 | Upgrade
|
| EBIT | 178.53 | 157.79 | 112.79 | 84.08 | 61.31 | 42.63 | Upgrade
|
| EBIT Margin | 74.21% | 74.09% | 69.84% | 67.32% | 65.60% | 62.63% | Upgrade
|
| Effective Tax Rate | 29.59% | 29.45% | 28.93% | 29.58% | 29.54% | 28.04% | Upgrade
|
| Revenue as Reported | 248.69 | 220.54 | 166.33 | 127.33 | 94.11 | 68.06 | Upgrade
|
| Advertising Expenses | - | 3.74 | 2.89 | 2.52 | 1.95 | 0.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.